MedTrace Logo

Rectal Misoprostol Versus Sublingual Misoprostol Prior to Myomectomy

NCT02716142 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2020-05-20

No results posted yet for this study

Summary

the aim of the study is To compare the effectiveness of rectally administered prostaglandin E1 synthetic analogue (misoprostol) 400 microgram versus sublingually administered misoprostol before myomectomy to decrease blood loss during and after the operation.

Conditions

  • Bleeding During Myomectomy

Interventions

DRUG

rectal misoprostol

patients will take 2 tablets of rectally misoprostol 400 microgram 60 minutes before the procedure

DRUG

sublingual misoprostol

patients will take 2 tablets of sublingual misoprostol 400 microgram 60 minutes before the procedure

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-03-01
Primary Completion
2019-12-31
Completion
2020-04-30

Countries

  • Egypt

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02716142 on ClinicalTrials.gov